Even if patents do issue and even if such patents cover our current or any future product candidates, third parties may challenge their scope, validity, or enforceability, which may result in such patents being 78 narrowed, invalidated, or held unenforceable
Key takeaways: PT-141 targets desire in the brain via melanocortin receptors, not blood flow like PDE5 inhibitors Low libido and erectile dysfunction are separate problems that respond to different treatments Testosterone drops ~1% per year after 30, affecting readiness more than desire PT-141 is taken as needed (1mg to 2mg) up to eight times per month PT-141 is available as either an injection or nasal spray Why Desire and Performance Are Two Different Problems Many men assume that low libido and erectile dysfunction are the same problem wearing different masks
That fee structure also means a patient who wants to discuss GLP-1 options can book a single $89 General Medical visit, have the conversation, and walk away with a prescription routed to a local pharmacy of their choice, without committing to a multi-month program
For the full show notes, please visit hubermanlab.com
10.1016/j.jhep.2020.04.033 64 HanM.SongY.ZhangX
